Phase 2 Randomized Double-blind Study to Assess Topical Zabalafin Hydrogel Vs Vehicle in Mild to Moderate AD.

Status:
RECRUITING

Trial end date:
2025-11-28

Target enrollment:

Participant gender:

A Phase 2b study investigating the efficacy of zabalafin in people with mild to moderate atopic dermatitis (eczema).

PHASE2

Alphyn Biologics